Abstract:Using deep sequencing combined with computational biology, we found that the failing human hearts (n=3) contain a significant amount of aberrant transcripts arising from widespread spurious intragenic transcription initiations. The same phenomenon was detected in failing mouse hearts (n=3) induced by pressure overload and ischemia injury. Therefore, we hypothesize that spurious transcripts accumulation is a causative factor promoting heart failure (HF). The SET domain containing 2 (Setd2), an H3K36 tri-methylase, is a key regulator for transcription fidelity. The Setd2 modified H3K36me3 prevents RNA polymerase II (Pol II) entry from the gene body and the subsequent cryptic transcription initiation. In the same cohort of failing human and mouse hearts, we found that the SETD2 and H3K36me3 levels were concurrently reduced. To further test our hypothesis, we generated cardiac-specific Setd2-Knockout mice. The mice (n≥8) developed a typical HF progression phenotype: initial compensatory hypertrophy followed by a gradually deteriorating HF with chamber dilation. Transcriptome analysis revealed an accumulation of spurious transcripts in pre-hypertrophic Setd2 -/- cardiomyocytes (n=3). New intragenic transcription initiation sites were identified by DECAP-seq in the knockout (n=3), confirming that the increased aberrant transcripts resulted from spurious Pol II entry. Using ribosome footprinting assay (n=3) to map the translation initiation sites, we found that the aberrant transcripts were partially translated into micro peptides in the Setd2 -/- heart, suggesting that the accumulated aberrant transcripts and micro peptides together promote cardiac hypertrophy. Finally, we developed transgenic mice overexpressing human SETD2 (Tg-MHC-SETD2) in the heart. SETD2 overexpression repressed TAC-induced accumulation of spurious transcripts in cardiomyocytes (n=3). The transgenic mice (n≥6) were resistant to pressure overload stress with less cardiac hypertrophy and improved cardiac contractility. Together, we report that dysregulated transcription fidelity causes adverse aberrant transcripts accumulation leading to cardiac hypertrophy and heart failure. This new mechanism provides potential new therapeutic targets for HF.

TRIM35 Monoubiquitinates H2B in Cardiac Cells, Implications for Heart Failure

The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy

Abstract 359: Tripartite Motif Protein 58 (trim58) is a Novel Regulator of Membrane Repair With Increased Expression in Failing Cardiac Muscle

Tripartite motif 32 prevents pathological cardiac hypertrophy.

TRIM55 Aggravates Cardiomyocyte Apoptosis after Myocardial Infarction Via Modulation of the Nrf2/HO-1 Pathway

Metabolic status differentiates Trp53inp2 function in pressure-overload induced heart failure

Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy

Abstract P2013: Transcription Fidelity Dysregulation In Heart Failure Pathogenesis

TRIM35 triggers cardiac remodeling by regulating SLC7A5-mediated amino acid transport and mTORC1 activation in fibroblasts

Involvement Of Autophagy In Cardiac Remodeling In Transgenic Mice With Cardiac Specific Over-Expression Of Human Programmed Cell Death 5

P53 Acetylation Exerts Critical Roles In Pressure Overload Induced Coronary Microvascular Dysfunction and Heart Failure

Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing TAK1-dependent Signaling Pathways

Tripartite Motif 8 Contributes To Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor Beta-Activated Kinase 1-Dependent Signaling Pathways

p53 Acetylation Exerts Critical Roles in Pressure Overload–Induced Coronary Microvascular Dysfunction and Heart Failure in Mice

Loss of Trim31 Worsens Cardiac Remodeling in a Mouse Model of Heart Failure by Enhancing the Activation of the NLRP3 Inflammasome

Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin

Unmasking Protein Phosphatase 2A Regulatory Subunit B as a Crucial Factor in the Progression of Dilated Cardiomyopathy

TRIM11 expression levels was downregulated and prevents ferroptosis of cardiomyocyte by Dusp6 in acute myocardial infarction

P53-Induced Inhibition of Hif-1 Causes Cardiac Dysfunction During Pressure Overload

The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes

METTL3-mediated m6A modification of OTUD1 aggravates press overload induced myocardial hypertrophy by deubiquitinating PGAM5